| P50 | author | Abdellah El Maghraoui | Q38639294 |
| P2093 | author name string | Abderrazak Nouijai | |
| | Ahmed Bezza | |
| | Lahsen Achemlal | |
| | El Mostapha Derouiche | |
| | Khalil Lebbar | |
| | Saida Tellal | |
| | Sanaa Bouhssain | |
| | Souad Chaouir | |
| P2860 | cites work | A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index | Q28299001 |
| | Interleukin-6 stimulates anterior pituitary hormone release in vitro | Q30459337 |
| | Bone mineral density in patients with recent onset rheumatoid arthritis: influence of disease activity and functional capacity | Q33565191 |
| | Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis | Q33565333 |
| | Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis | Q33566110 |
| | Evidence of impaired cartilage/bone turnover in patients with active ankylosing spondylitis | Q33578146 |
| | Androgens and ankylosing spondylitis: a role in the pathogenesis? | Q33692691 |
| | Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria | Q34055060 |
| | Gonadal and adrenal sex steroids in ankylosing spondylitis. | Q34085931 |
| | A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index | Q34307327 |
| | No alterations of serum levels of adrenal and gonadal hormones in patients with ankylosing spondylitis | Q35015359 |
| | Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis | Q35168125 |
| | Osteoporosis and ankylosing spondylitis | Q35853446 |
| | Association between prolactin and disease activity in systemic lupus erythematosus. Influence of statistical power | Q38547794 |
| | Cervical spine involvement in ankylosing spondylitis | Q38985057 |
| | Neurological complications of ankylosing spondylitis | Q40903928 |
| | Assessment of vertebral bone mineral density using volumetric quantitative CT. | Q41610289 |
| | Prolactin in systemic lupus erythematosus. | Q41934467 |
| | Thoracic high resolution computed tomography in patients with ankylosing spondylitis and without respiratory symptoms | Q43050643 |
| | Idiopathic retroperitoneal fibrosis and ankylosing spondylitis. A new case report | Q44245665 |
| | Blood prolactin under the effect of protirelin in spondylarthropathies. Treatment trial of 4 cases of reactive arthritis and 2 cases of psoriatic arthritis with bromocriptine | Q44474398 |
| | Fracture risk in patients with ankylosing spondylitis: a population based study. | Q44645563 |
| | Testosterone and testosterone free index in mild ankylosing spondylitis: relationship with bone mineral density and vertebral fractures | Q44804899 |
| | Skeletal status of men with early and late ankylosing spondylitis | Q44827491 |
| | Systemic osteopenia and mineralization defect in patients with ankylosing spondylitis. | Q46292729 |
| | Activation of 5-HT 1 serotonin receptors in the medial basal hypothalamus stimulates prolactin secretion in the unanaesthetized rat. | Q48134223 |
| | Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases. | Q49078220 |
| | Serum testosterone levels are not elevated in patients with ankylosing spondylitis. | Q50851950 |
| | Adenohypophyseal and sex hormones in pediatric rheumatic diseases. | Q51053604 |
| | Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. | Q52879871 |
| | Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus. | Q54000454 |
| | Appendicular and vertebral bone mass in ankylosing spondylitis. A comparison of plain radiographs with single- and dual-photon absorptiometry and with quantitative computed tomography | Q54263199 |
| | Bromocriptine induces immunological changes related to disease parameters in rheumatoid arthritis. | Q54443287 |
| | The development and validation of a radiographic grading system for the hip in ankylosing spondylitis: the bath ankylosing spondylitis radiology hip index | Q61713207 |
| | The bath ankylosing spondylitis radiology index (BASRI): A new, validated approach to disease assessment | Q61713215 |
| | Evidence for a Pathogenic Role of Nitric Oxide in Inflammation-Induced Osteoporosis | Q64448951 |
| | Testicular function in active ankylosing spondylitis. Therapeutic response to human chorionic gonadotrophin | Q67910458 |
| | Involvement of serotonin in prolactin release induced by electrical stimulation of the hypothalamus of the turkey (Meleagris gallopavo) | Q67979819 |
| | Osteoporosis in early ankylosing spondylitis: a primary pathological event? | Q69377409 |
| | Hyperprolactinemia in systemic lupus erythematosus? | Q71042380 |
| | No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus | Q71322195 |
| | Evidence that serotonin is involved in prolactin release by electrical stimulation of the medial basal hypothalamus in the rhesus monkey | Q71519082 |
| | Vertebral osteoporosis in ankylosing spondylitis | Q71749907 |
| | Bromocriptine immunomodulation of experimental SLE and primary antiphospholipid syndrome via induction of nonspecific T suppressor cells | Q72129254 |
| | Generalised bone loss in patients with early rheumatoid arthritis | Q72682386 |
| | Hyperprolactinemia in Reiter's syndrome | Q72819227 |
| | Osteoporosis, body composition, and bone turnover in ankylosing spondylitis | Q73101162 |
| | Significant loss of bone mass in patients with early, active ankylosing spondylitis: a followup study | Q73165844 |
| | Biochemical markers of bone turnover in seronegative spondylarthropathy: relationship to disease activity | Q73263623 |
| | Phenylbutazone can spuriously elevate unextracted testosterone assay results in patients with ankylosing spondylitis | Q73336793 |
| | Biochemical bone turnover markers in patients with ankylosing spondylitis | Q73737287 |
| | Changes in bone density in patients with ankylosing spondylitis: a two-year follow-up study | Q74437053 |
| | Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study | Q77296007 |
| | Ankylosing spondylitis. Clinical features | Q77803148 |
| | Concordance between abdominal scintigraphy using technetium-99m hexamethylpropylene amine oxime-labelled leucocytes and ileocolonoscopy in patients with spondyloarthropathies and without clinical evidence of inflammatory bowel disease | Q77989691 |
| P433 | issue | 4 | |
| P304 | page(s) | 346-351 | |
| P577 | publication date | 2004-12-08 | |
| P1433 | published in | Clinical Rheumatology | Q15754927 |
| P1476 | title | Bone turnover markers, anterior pituitary and gonadal hormones, and bone mass evaluation using quantitative computed tomography in ankylosing spondylitis | |
| P478 | volume | 24 | |